Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DUPILUMAB Cause Wrong technique in product usage process? 781 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 781 reports of Wrong technique in product usage process have been filed in association with DUPILUMAB (Dupixent). This represents 0.2% of all adverse event reports for DUPILUMAB.

781
Reports of Wrong technique in product usage process with DUPILUMAB
0.2%
of all DUPILUMAB reports
0
Deaths
15
Hospitalizations

How Dangerous Is Wrong technique in product usage process From DUPILUMAB?

Of the 781 reports, 15 (1.9%) required hospitalization.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DUPILUMAB. However, 781 reports have been filed with the FAERS database.

What Other Side Effects Does DUPILUMAB Cause?

Pruritus (44,279) Dermatitis atopic (33,670) Product use in unapproved indication (33,452) Rash (30,895) Injection site pain (27,799) Drug ineffective (23,712) Dry skin (20,239) Eczema (20,020) Product dose omission issue (18,189) Condition aggravated (16,459)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which DUPILUMAB Alternatives Have Lower Wrong technique in product usage process Risk?

DUPILUMAB vs DURAGESIC DUPILUMAB vs DUROGESIC DUPILUMAB vs DUROTEP MT DUPILUMAB vs DURVALUMAB DUPILUMAB vs DUTASTERIDE

Related Pages

DUPILUMAB Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process DUPILUMAB Demographics